Welcome Employees

A password is required to submit a request for an internal transfer. In order to obtain the password you can check any of the following resources: Login to the employee portal, check the current issue of "Regional High Points" newsletter, contact HR, or read this week's "Daily Announcements".

 

Close

Pathology Team



Accurate pathology results are of the utmost importance. Great care is given by our pathologists when reviewing a specimen of tissue to determine if cancer is present.
Our pathologists are typically the first members of our cancer team to look at a tumor. They draw on their education, expertise and the latest technology to evaluate what they discover. They help answer the all-important questions for clinicians and other health care providers: Does the patient have cancer? What type of cancer? What stage? What treatments might work?

Cytopathology provides diagnostic laboratory services for the early detection of cancer and tumor staging. Our cytotechnologists work with the pathologists to identify cancerous cells and microorganisms, and play an extremely important role in cancer prevention. They process several types of samples, including gynecologic (Pap smears) and non-gynecologic samples (body cavity fluids, urines, bronchial and peritoneal washings) and fine needle aspirations (FNAs) from various body sites.

Histopathology processes tissue specimens submitted to the department from surgery or from the various outpatient clinics. These specimens must be grossly identified and described, and then put through a process of fixation, embedding in paraffin and finally, cutting and staining prior to delivery to the pathologists for review and diagnosis. Surgeons often request a “frozen section” consult from a pathologist while in surgery. During this process a mass is surgically removed from a patient and a portion of it is frozen, cut, stained and placed on a slide for analysis — all while the patient is on the operating table. The pathologist’s analysis tells the surgeon how much of the cancer has been removed and the possibility of its recurring.

Molecular, genetic, and hematopathology Services are provided through consultation with an extensive roster of world-renowned experts in specification of rare types of cancer.

Meet our pathologists:
Claudia M. Croitoru, MD
Jason T. Fancey, MD
Ann B. Oaks, MD